H.R. 7970 · 119th Congress

STOP Nitazenes Act

Introduced on Mar 18, 2026 by Robert E. Latta (R-OH-5). 10 cosponsors, 1 of them from another party. Latest action (Jul 21, 2026): Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 21.

Stage
Introduced
Introduced
Mar 18, 2026
Cosponsors
10
1 from the other party
Policy area
Crime and Law Enforcement
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. 2Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

To amend the Controlled Substances Act to permanently schedule 2-benzylbenzimidazole opioids (commonly referred to as nitazenes) as Schedule 1 controlled substances, and for other purposes.

Subjects

  • Administrative law and regulatory procedures
  • Department of Justice
  • Drug trafficking and controlled substances

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Robert E. LattaR-OH-5Sponsor

Democrats · 1

Republicans · 9

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Mar 18, 2026Introduced in House
  2. Mar 18, 2026Introduced in House
  3. Mar 18, 2026 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. Mar 18, 2026 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  5. Mar 18, 2026 · HouseReferred to the Subcommittee on Health.
  6. Jun 25, 2026 · HouseSubcommittee Consideration and Mark-up Session Held
  7. Jun 25, 2026 · HouseForwarded by Subcommittee to Full Committee by Voice Vote.
  8. Jul 20, 2026 · HouseCommittee Consideration and Mark-up Session Held
  9. Jul 21, 2026 · HouseCommittee Consideration and Mark-up Session Held
  10. Jul 21, 2026 · HouseOrdered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 21.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. DRUG POLICY ALLIANCE2 reports
    $18.6K reported (all issues)
  2. DUE PROCESS INSTITUTE2 reports
    $30K reported (all issues)
  3. National Association of Criminal Defense Lawyers (NACDL)2 reports
    $30K reported (all issues)
  4. The Sentencing Project2 reports
    $31.5K reported (all issues)
  5. American Civil Liberties Union1 report
    $670K reported (all issues)
  6. American Medical Association1 report
    $5.1M reported (all issues)Federal contractor: AMERICAN MEDICAL ASSOCIATION$371K in contracts, FY2026AI match · 99%
  7. Southeast Georgia Hospital System1 report
    $24K reported (all issues)

Reports filed in 2026.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.